Skip to main content
Clinical Trials/ACTRN12619001435178
ACTRN12619001435178
Completed
未知

The influence of medical companions on a patient’s hypothetical decision to switch to abiosimilar.

Professor Keith Petrie0 sites79 target enrollmentOctober 16, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients taking biologic medications (e.g. adalimumab, etanercept, infliximab, rituximab, tocilizumab) for rheumatic diseases.
Sponsor
Professor Keith Petrie
Enrollment
79
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 16, 2019
End Date
November 24, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Keith Petrie

Eligibility Criteria

Inclusion Criteria

  • Patients are eligible to participate if they:
  • \- are attending an appointment with their rheumatologist/dermatologist at a clinic across the Auckland and Waitemata District Health Board,
  • \- are 18 years of age or over,
  • \- take a biologic medication (e.g., adalimumab, etanercept, infliximab, rituximab, tocilizumab),
  • \- have a companion (support person) that is 18 years of age or over.

Exclusion Criteria

  • Participants will be excluded from this study if they:
  • \- are unable to fill out the questionnaires,
  • \- cannot understand, read or write English.

Outcomes

Primary Outcomes

Not specified

Similar Trials